Protalix Biotherapeutics Inc
AMEX:PLX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
US |
|
G
|
Griffon Corp
F:GFF
|
US |
|
E
|
Edison International
DUS:EIX
|
US |
|
G
|
Genmab A/S
DUS:GE9
|
DK |
|
Atlanta Braves Holdings Inc
F:E45
|
US |
|
B
|
Beacon Minerals Ltd
ASX:BCN
|
AU |
Wall St Price Targets
PLX Price Targets Summary
Protalix Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for PLX is 11.22 USD with a low forecast of 10.1 USD and a high forecast of 12.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PLX's stock price target?
Price Target
11.22
USD
According to Wall Street analysts, the average 1-year price target for PLX is 11.22 USD with a low forecast of 10.1 USD and a high forecast of 12.6 USD.
What is the Revenue forecast for Protalix Biotherapeutics Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Protalix Biotherapeutics Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 6 years is 7%.
